(Q37665518)

English

A peptide-free, liposome-based oligosaccharide vaccine, adjuvanted with a natural killer T cell antigen, generates robust antibody responses in vivo

scientific article published on April 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

21 August 2017

A peptide-free, liposome-based oligosaccharide vaccine, adjuvanted with a natural killer T cell antigen, generates robust antibody responses in vivo (English)

1 reference

Europe PubMed Central

21 August 2017

oligosaccharide

1 reference

based on heuristic

inferred from title

author name string

S Deng

1

1 reference

Europe PubMed Central

21 August 2017

L Bai

2

1 reference

Europe PubMed Central

21 August 2017

R Reboulet

3

1 reference

Europe PubMed Central

21 August 2017

R Matthew

4

1 reference

Europe PubMed Central

21 August 2017

D A Engler

5

1 reference

Europe PubMed Central

21 August 2017

L Teyton

6

1 reference

Europe PubMed Central

21 August 2017

A Bendelac

7

1 reference

Europe PubMed Central

21 August 2017

P B Savage

8

1 reference

Europe PubMed Central

21 August 2017

publication date

1 April 2014

1 reference

Europe PubMed Central

21 August 2017

Chemical Science

1 reference

Europe PubMed Central

21 August 2017

5

1 reference

Europe PubMed Central

21 August 2017

4

1 reference

Europe PubMed Central

21 August 2017

1437-1441

1 reference

Europe PubMed Central

21 August 2017

Natural killer T (NKT)-B-cell interactions promote prolonged antibody responses and long-term memory to pneumococcal capsular polysaccharides

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3966715

23 August 2017

Clustered carbohydrates in synthetic vaccines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3966715

23 August 2017

Progress toward a Staphylococcus aureus vaccine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3966715

23 August 2017

Cancer vaccines and carbohydrate epitopes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3966715

23 August 2017

Invariant natural killer T cells recognize glycolipids from pathogenic Gram-positive bacteria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3966715

23 August 2017

Estimating the direct impact of new conjugate vaccines against invasive pneumococcal disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3966715

23 August 2017

Identification of the smallest structure capable of evoking opsonophagocytic antibodies against Streptococcus pneumoniae type 14.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3966715

23 August 2017

Recent developments in synthetic oligosaccharide-based bacterial vaccines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3966715

23 August 2017

Immune responses to polysaccharides: lessons from humans and mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3966715

23 August 2017

Bacterial capsular antigens. Structural patterns of capsular antigens

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3966715

23 August 2017

Comparative properties and methods of preparation of lipid vesicles (liposomes).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3966715

23 August 2017

Multivalent glyco(cyclo)peptides.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3966715

6 September 2017

Prevnar 13, the new 13-valent pneumococcal conjugate vaccine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3966715

6 September 2017

Chemo-enzymatic synthesis of a tetra- and octasaccharide fragment of the capsular polysaccharide of Streptococcus pneumoniae type 14.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3966715

1 September 2018

A modified alpha-galactosyl ceramide for staining and stimulating natural killer T cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/24683450

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine

1 reference

https://pubmed.ncbi.nlm.nih.gov/24683450

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1039/C3SC53471E

1 reference

Europe PubMed Central

21 August 2017

1 reference

Europe PubMed Central

21 August 2017

1 reference

Europe PubMed Central

21 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37665518&oldid=1720829265"